Phibro Animal Health (PAHC) has a profit margin of 6.35%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for PAHC is 6.35% as of March 2026. That compares with 2.67% in the prior-year period — up 137.8% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Phibro Animal Health's historical trend and sector peers before judging valuation or financial health.
Over the past year, PAHC's profit margin moved from 2.67% to 6.35% — a 137.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Phibro Animal Health's valuation or profitability profile.
Against Healthcare companies, PAHC currently prints 6.35% for profit margin, while the sector average sits near 14.34%. That is roughly 55.7% below the sector mean. Large gaps often invite a closer look at Phibro Animal Health's growth, margins, and balance sheet.
Profit Margin shows how effectively Phibro Animal Health converts resources into returns. At 6.35%, PAHC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 2.67% in the prior-year period — up 137.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting PAHC's profit margin (6.35%), review year-over-year change from 2.67%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.